Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A quarter century after the World Trade Center attacks, cancer has become the defining health crisis for survivors. The number receiving federal cancer treatment aid has nearly tripled in five years, and long-latency malignancies like mesothelioma are only now entering their expected diagnosis windows. Experts warn the peak may still be years away — and a new $50M federal study will finally track the children who were exposed.
Twenty-five years after 9/11, the health fallout is far from over. Cancer has emerged as the dominant long-term consequence for the roughly 400,000 people exposed to the toxic dust, smoke, and debris of Lower Manhattan. What began as a respiratory crisis has evolved into what clinicians are calling a "third wave" — a surge of blood cancers, thyroid, lung, prostate, and digestive cancers that can take decades to develop. Breast cancers in this group are appearing about four years earlier than the national average, and an unusual number of lung cancer patients are women who never smoked.
The federal World Trade Center Health Program, which provides no-cost monitoring and treatment, now documents over 57,000 certified cancer cases. Encouragingly, program participants show significantly lower cancer-specific and all-cause mortality than comparable non-enrolled populations. Clinicians are urged to ask patients about 9/11 exposure history and connect eligible individuals to the program.
By the Numbers
Why it matters: Experts caution the peak may still be decades away. With long-latency cancers like mesothelioma only now entering their expected windows, the 9/11 health crisis demands sustained clinical vigilance, proactive screening, and expanded enrollment in the WTC Health Program.
